Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis sees limited impact from Japan Diovan scandal
Reuters
Thursday, October 3, 2013 - 9:11am
tags:
Novartis, Japan, Diovan
Dendreon: Time To Prove Itself Or Perish
Seeking Alpha
Thursday, October 3, 2013 - 9:11am
tags:
Dendreon, prostate cancer, JNJ, Provenge, Medivation
Eli Lilly's ramucirumab for gastric cancer shows positive Phase III results
Yahoo/Fly on the Wall
Thursday, October 3, 2013 - 9:09am
tags:
Eli Lilli, ramucirumab, gastric cancer
Lilly Challenged to Hit Sales Goal Announces Buyback
Bloomberg
Thursday, October 3, 2013 - 9:09am
tags:
Eli Lilly
Astex Pharma shareholder opposes $886 mln bid by Otsuka
Yahoo/Reuters
Thursday, October 3, 2013 - 9:08am
tags:
Astex, Otsuka, shareholders, M&A
Judge sweeps aside AstraZeneca shield against Nexium competitor
Fierce Pharma
Wednesday, October 2, 2013 - 2:59pm
tags:
AstraZeneca, Hanmi Pharma, Nexium, Esomezol
With Actavis acquisition complete, Chilcott announces layoffs in N.J.
NJ Biz
Wednesday, October 2, 2013 - 2:58pm
tags:
Actavis, Warner Chilcott, layoffs, M&A
Stryker sues Biomet, sales reps over alleged poaching scheme
Mass Device
Wednesday, October 2, 2013 - 2:54pm
tags:
devices, Biomet, Stryker
Wright Medical Deal Chances Enhanced After Mako: Real M&A
Bloomberg
Wednesday, October 2, 2013 - 2:46pm
tags:
Wright Medical, MAKO, M&A, devices, Stryker
Greater Fools Love Delcath, Zalicus On Orphan Drug Derpitude
TheStreet.com
Wednesday, October 2, 2013 - 2:38pm
tags:
Delcath, Zalicus, orphan drugs, Chemosat, liver cancer
Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
Wednesday, October 2, 2013 - 10:54am
tags:
cancer immunotherapy, Merck, MK-3475, nivolumab, Bristol-Myers Squibb, Roche, MPDL3280A, PDL-1
FDA Approval Of Roche Cancer Drug Signals A New Paradigm
Pharmalot
Wednesday, October 2, 2013 - 10:42am
tags:
Roche, drug approvals, FDA, Perjeta
Interview with Ken Frazier about Merck reorg and layoffs
Pharmalot
Wednesday, October 2, 2013 - 10:37am
tags:
Kenneth Frazier, Merck, layoffs, Pharma CEOs
Analyst's Celldex Call Another Sign Of Biotech Stock Bubble
TheStreet.com
Wednesday, October 2, 2013 - 10:25am
tags:
Celldex, CDX-1127
StemCells receives FDA authorization of IND for spinal cord injury
Yahoo/Fly on the Wall
Wednesday, October 2, 2013 - 10:24am
tags:
FDA, spinal cord injury, StemCells, HuCNS-SC
Investing Smart: Biotechs, Effective Therapies And Shareholder-Friendly CEOs
Seeking Alpha
Wednesday, October 2, 2013 - 10:15am
tags:
biotech, Jazz Pharmaceuticals, Questcor, Spectrum Pharmaceuticals, NeoStem, NewLink Genetics, Dendreon, Galena Biopharma, Roche, ImmunoCellular Therapeutics
Incyte Has First-Mover Advantage
Motley Fool
Wednesday, October 2, 2013 - 10:10am
tags:
Incyte, myelofibrosis, Jakafi, Novartis
PDL BioPharma Provides $60 Million in Financing to LENSAR
Yahoo
Wednesday, October 2, 2013 - 10:09am
tags:
PDL Biopharma, LensAR, refractive cataract surgery, devices
ADHD Pill Faces High Hurdle in Europe as Stigma Persists
Bloomberg
Wednesday, October 2, 2013 - 10:06am
tags:
Europe, ADHD, Vyvanse, Shire
J&J Says Boehringer Doxil Dispute May Cause Shortage
Bloomberg
Wednesday, October 2, 2013 - 10:05am
tags:
JNJ, Boehringer Ingelheim, drug shortages, Doxil, ovarian cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.